According to the latest report by IMARC Group, titled "Mouth Ulcer Treatment Market Report by Formulation (Gel, Spray, Mouthwash, Lozenges), Drug Class (Corticosteroids, Anesthetics, Analgesics, Antimicrobials, Antihistamines), Indication (Aphthous Stomatitis, Oral Lichen Planus, and Others), and Region 2025-2033," the global mouth ulcer treatment market size reached USD 1.97 Billion in 2024. Mouth ulcers are round or oval sores that occur on the mucous membrane of the oral cavity. They usually appear on the soft tissues of the mouth, including the lips, cheeks, gums, tongue and the roof. They are commonly painful in nature that makes it uncomfortable for the individual to eat or drink properly. These sores are mostly harmless and recede in a few days. However, their occurrence can also indicate mouth cancer, certain medical conditions or viral infections, such as herpes simplex. In order to combat this, various drugs and treatments are prescribed by healthcare professionals. Some of the most common classes of drugs utilized to treat these ulcers include analgesics, anesthetics and antihistamines.
Global Mouth Ulcer Treatment Market Trends:
The market is primarily driven by the increasing incidences of mouth ulcers, especially among the geriatric population. Along with this, numerous governments and market players are organizing campaigns to impart knowledge regarding the importance of oral hygiene. This, along with the growing awareness about the available treatment options for mouth ulcers, is creating a positive outlook for the market. Furthermore, several key players are increasing investments in the development of innovative treatment products for these ulcers. This has led to the introduction of new drugs with fewer side effects and rapid healing action. They have also launched a range of product variants that prevent recurring ulcerations among patients. This, along with the inflating disposable incomes and rising consumer expenditure capacities, is expected to provide an impetus to the market growth. Looking forward, the market value is projected to reach USD 2.55 Billion by 2033, expanding at a CAGR of 2.74% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Formulation, Drug Class, Indication, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Companies Covered | Blistex Inc, Church & Dwight Co. Inc., 3M Company, Colgate-Palmolive Company, GSK plc., Bristol-Myers Squibb Company, and Pfizer Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal